Figure 1From: Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulationsGMZ2 formulations, immunization protocol and analysis schedule.Back to article page